This finding is supported by a study on a negative regulator in NK cells, which indicated that CIS is a critical suppressor of IL-15 signaling in NK cells via interaction with the activation loop peptides of JAK1 and JAK3 [7]. The gene discussed is IL15; the disease is in situ carcinoma.